References
- Ahn JC, Teng PC, Chen PJ et al. (2021) Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology 73:422–436.
https://doi.org/10.1002/hep.31165 - Aijtink VJ, Rutten VC, Meijer BEM et al. (2022) Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: A Systematic review and meta-analysis. Ann Surg 276:239–245.
https://doi.org/10.1097/SLA.0000000000005476 - Carroll C, Young F (2021) Intraoperative cell salvage. BJA Educ 21:95–101.
https://doi.org/10.1016/j.bjae.2020.11.007 - Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J et al. (2021) Circulating tumor cells in hepatocellular carcinoma: A comprehensive review and critical appraisal. Int J Mol Sci 22:13073.
https://doi.org/10.3390/ijms222313073 - Ganesan P, Kulik LM (2023) Hepatocellular carcinoma: New developments. Clin Liver Dis 27:85–102.
https://doi.org/10.1016/j.cld.2022.08.004 - Ivanics T, Shubert CR, Muaddi H et al. (2021) Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: A propensity score-matched analysis. Ann Surg Oncol 28:6816–6825.
https://doi.org/10.1245/s10434-021-09863-6 - Jiang Y, Han Q, Zhao H et al. (2021) Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res 40:13.
https://doi.org/10.1186/s13046-020-01808 - Koch DT, Yu H, Beirith I et al. (2023) Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells. J Transl Med 21:876.
https://doi.org/10.1186/s12967-023-04615-4 - Lin D, Shen L, Luo M et al. (2021) Circulating tumor cells: Biology and clinical significance. Signal Transduct Target Ther 6:404.
https://doi.org/10.1038/s41392-021-00817-8 - Liu Y, Tao S, Liao L et al. (2020) TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat Commun 11:348.
https://doi.org/10.1038/s41467-019-14190-2 - Obore N, Liuxiao Z, Haomin Y et al. (2022) Intraoperative cell salvage for women at high risk of postpartum hemorrhage during cesarean section: A systematic review and meta-analysis. Reprod Sci 29:3161–3176.
https://doi.org/10.1007/s43032-021-00824-8 - Peng C, Li X, Ao F et al. (2023) Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1. J Transl Med 21:218.
https://doi.org/10.1186/s12967-023-04067-w - Pinto MA, Grezzana-Filho TJM, Chedid AD et al. (2021) Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma. Langenbecks Arch Surg 406:67–74.
https://doi.org/10.1007/s00423-020-01997-7 - Rajasekaran RB, Palmer AJR, Whitwell D et al. (2021) The role of intraoperative cell salvage for musculoskeletal sarcoma surgery. J Bone Oncol 30:100390.
https://doi.org/10.1016/j.jbo.2021.100390 - Sun B, Ji WD, Wang WC et al. (2023) Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma. Front Genet 14:1265866.
https://doi.org/10.3389/fgene.2023.1265866 - Vogel A, Meyer T, Sapisochin G et al. (2022) Hepatocellular carcinoma. Lancet 400:1345–1362.
https://doi.org/10.1016/S0140-6736)22)01200-4 - Walton TJ, Huntley D, Whitehouse SL et al. (2023) Intraoperative cell salvage in revision hip arthroplasty. Bone Joint J 105-b:1038–1044.
https://doi.org/10.1302/0301-620X.105B10.BJJ-2023-0300.R1 - Wang Y, Deng B (2023) Hepatocellular carcinoma: Molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 42:629–652.
https://doi.org/10.1007/s10555-023-10084-4 - Weller A, Seyfried T, Ahrens N et al. (2021) Cell salvage during liver transplantation for hepatocellular carcinoma: A retrospective analysis of tumor recurrence following irradiation of the salvaged blood. Transplant Proc 53:1639–1644.
https://doi.org/10.1016/j.transproceed.2021.03.025 - Yang X, Yang C, Zhang S et al. (2024) Precision treatment in advanced hepatocellular carcinoma. Cancer Cell 42:180–197.
https://doi.org/10.1016/j.ccell.2024.01.007